Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD in Anxiety
NCT04267679Phase 2Withdrawn
- Sponsor
- CB2 Insights
- Start
- Mar 2020
- Primary completion
- Dec 2020
01
Overview
A Phase 2 trial of Zygel in generalized anxiety disorder (GAD), sponsored by CB2 Insights. Planned start Mar 2020; status: withdrawn.
02
Drugs
Zygel
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT04267679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04267679.